ASP015K

J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
Tue, 12/2/14 - 09:25 am
JNJ
Astellas
rheumatoid arthritis
ASP015K
JAK inhibitors
J&J and Astellas Collaborate
Yahoo/Zacks
Thu, 10/4/12 - 10:42 am
JNJ
Astellas
JAK inhibitors
ASP015K
rheumatoid arthritis